Katherine Cheung

Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates

Jeremy I. Levin, J.M. Chen, Katherine Cheung et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 49 citations · Full text

Acyclic Sulfonamide Hydroxamates, Medicinal Chemistry, Pharmaceutical Science +11

Synthesis and Biological Activity of Analogues of the Antimicrotubule Agent<i>N</i>,β,β-Trimethyl-<scp>l</scp>-phenylalanyl-<i>N</i>-[(1<i>S</i>,2<i>E</i>)-3-carboxy-1-isopropylbut-2-enyl]-<i>N</i>¹,3-dimethyl-<scp>l</scp>-valinamide (HTI-286)

Arie Zask, Gary H. Birnberg, Katherine Cheung et al. · Journal of Medicinal Chemistry · 2004 · 48 citations · Full text

Bioorganic Chemistry, Antiparasitic Agent, Novel Analogues +19

The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)

Thomas Nittoli, Russell G. Dushin, Charles L. Ingalls et al. · European Journal of Medicinal Chemistry · 2009 · 25 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +11

D-piece modifications of the hemiasterlin analog HTI-286 produce potent tubulin inhibitors

Arie Zask, Gary H. Birnberg, Katherine Cheung et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 20 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +7